Trevi Therapeutics TRVI
NASDAQ TRVI
$14.32 -0.10 (-0.69%)
At close: Sep 30, 2026 · 4:00 PM EDT

Trevi Therapeutics (TRVI) Total Non-Current Liabilities (2022)

Updated

Trevi Therapeutics (TRVI) posted Total Non-Current Liabilities of $15.55 million for Q4 2022, down 15.7% from the prior quarter.

Analysis

Trevi Therapeutics (TRVI) Total Non-Current Liabilities (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Trevi Therapeutics 2.05 Bn 2.05 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 15.55 Mn
Sep 30, 2022 18.44 Mn
Jun 30, 2022 20.86 Mn
API Access

Trevi Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TRVI&period=max&api_key=YOUR_API_KEY